Zurcher Kantonalbank Zurich Cantonalbank Acquires New Holdings in United States Antimony Co. $UAMY

Zurcher Kantonalbank Zurich Cantonalbank bought a new position in shares of United States Antimony Co. (NYSE:UAMY) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 45,197 shares of the company’s stock, valued at approximately $227,000.

Several other hedge funds have also recently bought and sold shares of the stock. CoreCap Advisors LLC acquired a new position in shares of United States Antimony in the fourth quarter valued at approximately $27,000. Geneos Wealth Management Inc. bought a new stake in United States Antimony in the 3rd quarter valued at $49,000. Focus Partners Wealth acquired a new position in United States Antimony in the 3rd quarter worth $62,000. Jones Financial Companies Lllp increased its holdings in United States Antimony by 28.1% during the 3rd quarter. Jones Financial Companies Lllp now owns 10,130 shares of the company’s stock worth $63,000 after purchasing an additional 2,223 shares in the last quarter. Finally, Evernest Financial Advisors LLC acquired a new stake in shares of United States Antimony in the 3rd quarter valued at about $66,000. 9.49% of the stock is currently owned by institutional investors and hedge funds.

United States Antimony Trading Down 5.1%

NYSE UAMY opened at $11.15 on Wednesday. The company has a market cap of $1.59 billion, a PE ratio of -222.92 and a beta of 0.43. United States Antimony Co. has a 12 month low of $1.94 and a 12 month high of $19.71. The stock has a 50 day moving average of $9.54 and a 200-day moving average of $8.25.

United States Antimony (NYSE:UAMY) last issued its earnings results on Thursday, March 19th. The company reported ($0.01) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.01). United States Antimony had a negative net margin of 11.05% and a negative return on equity of 6.14%. The business had revenue of $13.03 million for the quarter, compared to the consensus estimate of $11.75 million. As a group, sell-side analysts predict that United States Antimony Co. will post 0.03 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on UAMY. Alliance Global Partners reaffirmed a “buy” rating on shares of United States Antimony in a research report on Wednesday, February 11th. Weiss Ratings began coverage on shares of United States Antimony in a research note on Friday, March 20th. They issued a “sell (d-)” rating on the stock. HC Wainwright boosted their price target on shares of United States Antimony from $10.25 to $11.50 and gave the stock a “buy” rating in a research report on Monday, March 23rd. Finally, B. Riley Financial increased their price objective on shares of United States Antimony from $9.00 to $11.00 and gave the stock a “buy” rating in a research note on Tuesday, February 24th. Five research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $9.17.

United States Antimony Profile

United States Antimony Corporation is a specialized mining and chemical company focused primarily on the production and processing of antimony and antimony-based compounds. The company operates its own extraction and milling facilities to recover antimony metal and antimony trioxide, which serve as critical raw materials in industries such as flame retardants for plastics and textiles, catalysts for chemical processes, and additives for glass and ceramics. In addition to antimony, United States Antimony maintains smaller-scale gold and silver operations in Mexico that provide supplementary revenue streams and diversification of its mineral portfolio.

Founded in the mid-20th century, United States Antimony has evolved from a single‐mine operator into a multinational enterprise with mining and processing sites in both the United States and Mexico.